City
Epaper

Canada to donate 17.7mn AstraZeneca vax to other countries

By IANS | Updated: July 13, 2021 09:40 IST

Ottawa, July 13 Canada announced its decision to donate 17.7 million doses of the AstraZeneca coronavirus vaccine to ...

Open in App

Ottawa, July 13 Canada announced its decision to donate 17.7 million doses of the AstraZeneca coronavirus vaccine to low- and middle-income countries.

While addressing a press conference on Monday, Procurement Minister Anita Anand said that the vaccine doses are a part of the Canadian government's advance purchase agreement with the company and would be distributed through COVAX, reports Xinhua news agency.

COVAX is a global vaccine-sharing initiative jointly co-ordinated by the World Health Organization, the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance.

"This donation is a result of our proactive approach to securing hundreds of millions of Covid-19 vaccines in our initial contracts. With close to 55 million vaccines in Canada, and with the demands of the provinces and territories for this vaccine being met, we are now in a position to donate these excess doses," Anand said.

The government also announced it's partnering with Unicef on a donation-matching fundraising campaign to encourage Canad to donate vaccine doses by contributing C$10.

All donations by Canad will be matched by the federal government, up to a maximum of C$10 million).

The campaign runs until September 6.

Anand said that if the Unicef campaign is maxed out, it will provide enough money to vaccinate 4 million people in countries where inoculation campaigns are struggling to meet demand.

She said that the AstraZeneca doses are coming from the advance purchase agreement the government struck with the company and that these doses, which will be manufactured in the United States, will start being delivered to COVAX in the coming weeks.

The Public Health Agency of Canada and the National Advisory Committee on Immunization have "recommended" mRNA vaccines such as Moderna or Pfizer over AstraZeneca's product.

The recommendation was made in the wake of evidence suggesting that, in rare cases, the AstraZeneca vaccine could cause potentially fatal blood clots in some people.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Anita AnandcanadaXinhuaOttawaAstrazenecaIndia canadaAstrazeneca plc.Astrazeneca plcAstra zenecaRoche company
Open in App

Related Stories

MumbaiMumbai: Four Youths Duped of ₹14.72 Lakh with Fake Canada Job Promises

MumbaiMumbai: Canadian PM Mark Carney Landing Tomorrow, Bilateral Talks With PM Modi in Delhi Scheduled

CricketT20 World Cup 2026 Standings: Updated Points Table After Australia vs Oman Match

CricketT20 World Cup 2026 Standings: Updated Points Table After Afghanistan vs Canada Match

CricketAFG vs CAN LIVE Cricket Streaming: When and Where To Watch Afghanistan vs Canada T20 World Cup 2026 Match

Politics Realted Stories

Politics"Serious developmental and employment challenges": BJP's Anil K Antony slams CM Pinarayi Vijayan

Politics"Will take strongest action against Pawan Khera": Assam CM Himanta Biswa Sarma

PoliticsRajya Sabha Chairman, Lok Sabha Speaker reject opposition notices seeking removal of CEC Gyanesh Kumar

PoliticsStrong booth network is party's real strength: BJP leader Sanjay Tandon

PoliticsBaramati not just constituency, but Dada's heartbeat; every Baramatikar matters: Sunetra Ajit Pawar